147 related articles for article (PubMed ID: 10500617)
1. Comparative study of antifibrinolytic drugs in orthotopic liver transplantation.
Dalmau A; Sabaté A; Acosta F; Garcia-Huete L; Koo M; Reche M; Rafecas A; Figueras J; Jaurrieta E
Transplant Proc; 1999 Sep; 31(6):2361-2. PubMed ID: 10500617
[No Abstract] [Full Text] [Related]
2. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation.
Kaspar M; Ramsay MA; Nguyen AT; Cogswell M; Hurst G; Ramsay KJ
Anesth Analg; 1997 Aug; 85(2):281-5. PubMed ID: 9249100
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.
Dalmau A; Sabaté A; Acosta F; Garcia-Huete L; Koo M; Sansano T; Rafecas A; Figueras J; Jaurrieta E; Parrilla P
Anesth Analg; 2000 Jul; 91(1):29-34. PubMed ID: 10866882
[TBL] [Abstract][Full Text] [Related]
4. The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial.
Verma K; Errico T; Diefenbach C; Hoelscher C; Peters A; Dryer J; Huncke T; Boenigk K; Lonner BS
J Bone Joint Surg Am; 2014 May; 96(10):e80. PubMed ID: 24875032
[TBL] [Abstract][Full Text] [Related]
5. Antifibrinolytic therapy.
Schisano G; Nina P
J Neurosurg; 1997 Sep; 87(3):486-7. PubMed ID: 9285628
[No Abstract] [Full Text] [Related]
6. Antifibrinolytic Use in the Perioperative Setting: Aminocaproic Acid and Tranexamic Acid.
Golembiewski J
J Perianesth Nurs; 2015 Dec; 30(6):560-563. PubMed ID: 26596393
[No Abstract] [Full Text] [Related]
7. Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization.
Hardy JF; Bélisle S; Dupont C; Harel F; Robitaille D; Roy M; Gagnon L
Ann Thorac Surg; 1998 Feb; 65(2):371-6. PubMed ID: 9485231
[TBL] [Abstract][Full Text] [Related]
8. Are antifibrinolytic agents effective in the treatment of aneurysmal subarachnoid hemorrhage?
Eastin TR; Snipes CD; Seupaul RA
Ann Emerg Med; 2014 Dec; 64(6):658-9. PubMed ID: 24954579
[No Abstract] [Full Text] [Related]
9. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
[TBL] [Abstract][Full Text] [Related]
10. Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series.
Simon RP; Oromendia C; Sanso LM; Ramos LG; Rajwani K
Pulm Pharmacol Ther; 2020 Feb; 60():101871. PubMed ID: 31783097
[TBL] [Abstract][Full Text] [Related]
11. Safety of tranexamic acid in pediatric cardiac surgery: what we do not know.
Faraoni D
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1550-1; author reply 1551-2. PubMed ID: 21497106
[No Abstract] [Full Text] [Related]
12. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial.
Camarasa MA; Ollé G; Serra-Prat M; Martín A; Sánchez M; Ricós P; Pérez A; Opisso L
Br J Anaesth; 2006 May; 96(5):576-82. PubMed ID: 16531440
[TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial.
Peters A; Verma K; Slobodyanyuk K; Cheriyan T; Hoelscher C; Schwab F; Lonner B; Huncke T; Lafage V; Errico T
Spine (Phila Pa 1976); 2015 Apr; 40(8):E443-9. PubMed ID: 25868100
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis.
Molenaar IQ; Warnaar N; Groen H; Tenvergert EM; Slooff MJ; Porte RJ
Am J Transplant; 2007 Jan; 7(1):185-94. PubMed ID: 17227567
[TBL] [Abstract][Full Text] [Related]
15. Blood Conservation Using Tranexamic Acid Is Not Superior to Epsilon-Aminocaproic Acid After Total Knee Arthroplasty.
Boese CK; Centeno L; Walters RW
J Bone Joint Surg Am; 2017 Oct; 99(19):1621-1628. PubMed ID: 28976426
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma concentrations of epsilon aminocaproic acid and tranexamic acid in horses.
Fletcher DJ; Brainard BM; Epstein K; Radcliffe R; Divers T
J Vet Intern Med; 2013; 27(6):1589-95. PubMed ID: 24118238
[TBL] [Abstract][Full Text] [Related]
17. Pro: Antifibrinolytics Should Be Used in Routine Cardiac Cases Using Cardiopulmonary Bypass (Unless Contraindicated).
Pustavoitau A; Faraday N
J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):245-7. PubMed ID: 26619951
[No Abstract] [Full Text] [Related]
18. Dual-route tranexamic acid to reduce blood loss in coronary artery bypass graft surgery: a randomized controlled trial.
Prokopchuk-Gauk O; Rosin MW; Mycyk TR; Lim HJ; Brose K
Can J Anaesth; 2016 Sep; 63(9):1110-1. PubMed ID: 27334724
[No Abstract] [Full Text] [Related]
19. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding.
Choudhuri P; Biswas BK
Ethiop J Health Sci; 2015 Jul; 25(3):273-8. PubMed ID: 26633931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
